Furthermore, Loves et al., in the further corroboration of the aforementioned observation, demonstrated that treatment with aromatase inhibitors induced the same changes in hormonal concentrations as weight loss in hypogonadal men with obesity [61]. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.